(Q37289418)

19 August 2017

1 reference

title

Biochemistry of B-type natriuretic peptide--where are we now? (English)

1 reference

19 August 2017

Johannes Mair

1

1 reference

19 August 2017

publication date

1 January 2008

1 reference

Clinical Chemistry and Laboratory Medicine

19 August 2017

published in

1 reference

19 August 2017

volume

46

1 reference

19 August 2017

issue

11

1 reference

19 August 2017

page(s)

1507-1514

1 reference

A rapid and potent natriuretic response to intravenous injection of atrial myocardial extract in rats

19 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2008.295

Purification and complete amino acid sequence of alpha-human atrial natriuretic polypeptide (alpha-hANP)

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2008.295

The impact of cardiac natriuretic peptide determination on the diagnosis and management of heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2008.295

Diagnostic accuracy and prognostic relevance of the measurement of cardiac natriuretic peptides: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2008.295

Clinical applications of B-type natriuretic peptide (BNP) testing.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2008.295

Natriuretic peptides, their receptors, and cyclic guanosine monophosphate-dependent signaling functions

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2008.295

Two cardiac natriuretic peptide genes (atrial natriuretic peptide and brain natriuretic peptide) are organized in tandem in the mouse and human genomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2008.295

Molecular regulation of the brain natriuretic peptide gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2008.295

Upregulation of corin gene expression in hypertrophic cardiomyocytes and failing myocardium

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2008.295

Processing of pro-atrial natriuretic peptide by corin in cardiac myocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2008.295

Which of the cardiac natriuretic peptides is most effective for the treatment of congestive heart failure, renal failure and cancer?

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2008.295

The precursor to B-type natriuretic peptide is an O-linked glycoprotein

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2008.295

Stretch-induced hypertrophic growth of cardiocytes and processing of brain-type natriuretic peptide are controlled by proprotein-processing endoprotease furin

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2008.295

Salt-resistant hypertension in mice lacking the guanylyl cyclase-A receptor for atrial natriuretic peptide

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2008.295

Cardiac fibrosis in mice lacking brain natriuretic peptide

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2008.295

Molecular forms of human brain natriuretic peptide in plasma

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2008.295

Characterization of molecular forms of probrain natriuretic peptide in human plasma

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2008.295

The amino terminal regions of proBNP and proANP oligomerise through leucine zipper-like coiled-coil motifs

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2008.295

Human N-terminal proBNP is a monomer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2008.295

Evidence for functional heterogeneity of circulating B-type natriuretic peptide.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2008.295

Dipeptidyl-peptidase IV converts intact B-type natriuretic peptide into its des-SerPro form

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2008.295

Successive action of meprin A and neprilysin catabolizes B-type natriuretic peptide.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2008.295

Quantitative mass spectral evidence for the absence of circulating brain natriuretic peptide (BNP-32) in severe human heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2008.295

Assay for measurement of intact B-type natriuretic peptide prohormone in blood

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2008.295

Immunoreactivity and guanosine 3',5'-cyclic monophosphate activating actions of various molecular forms of human B-type natriuretic peptide

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2008.295

The brain natriuretic peptide (BNP) precursor is the major immunoreactive form of BNP in patients with heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2008.295

Delayed metabolism of human brain natriuretic peptide reflects resistance to neutral endopeptidase.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2008.295

Using the single-compartment ratio model to calculate half-life, NT-proBNP as an example

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2008.295

Cross-reactivity of BNP, NT-proBNP, and proBNP in commercial BNP and NT-proBNP assays: preliminary observations from the IFCC Committee for Standardization of Markers of Cardiac Damage.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2008.295

21 January 2018

Identifiers

DOI

10.1515/CCLM.2008.295

1 reference

19 August 2017

1 reference